HomeVRX • SWX
Bausch Health Companies Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.53B | 5.29% |
Operating expense | 1.31B | 3.89% |
Net income | 148.00M | 1,380.00% |
Net profit margin | 5.85 | 1,292.86% |
Earnings per share | 0.91 | -7.99% |
EBITDA | 763.00M | 2.97% |
Effective tax rate | 8.57% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.73B | 190.25% |
Total assets | 27.27B | 2.91% |
Total liabilities | 27.12B | 1.49% |
Total equity | 147.00M | — |
Shares outstanding | 369.79M | — |
Price to book | -10.36 | — |
Return on assets | 4.25% | — |
Return on capital | 5.28% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 148.00M | 1,380.00% |
Cash from operations | 289.00M | -23.95% |
Cash from investing | -100.00M | -26.58% |
Cash from financing | 358.00M | 184.43% |
Net change in cash | 586.00M | 543.94% |
Free cash flow | 241.38M | -46.55% |
Previous close
CHF 21.44
Year range
CHF 21.44 - CHF 21.44
Market cap
2.78B USD
P/E ratio
-
Dividend yield
-
About
Bausch Health Companies Inc. is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
CEO
Founded
1959
Headquarters
Website
Employees
20,700
